Fund Holdings — SILVERARC CAPITAL MANAGEMENT, LLC

Total Portfolio Value:
$820.95M
Total Bought:
$222.13M
Total Sold:
$257.92M
Net Transaction:
-$35.79M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Kodiak Sciences Inc.(KOD)546,256750,170+203,914$21.28M$71.12M8.66%+$49.83M
Celcuity Inc.(CELC)500,996803,193+302,197$52.41M$63.87M7.78%+$11.46M
Cogent Biosciences, Inc.(COGT)1,280,7071,574,698+293,991$49.56M$50.42M6.14%+$858.5K
UroGen Pharma Ltd.(URGN)1,301,9791,148,689-153,290$47.91M$46.67M5.69%-$1.24M
Immunome, Inc.(IMNM)2,017,0092,092,715+75,706$42.74M$45.01M5.48%+$2.27M
Monte Rosa Therapeutics, Inc.(GLUE)1,108,2953,112,773+2,004,478$26.82M$37.14M4.52%+$10.31M
Sagimet Biosciences Inc.COM SER A(SGMT)2,927,6983,745,990+818,292$22.63M$37.01M4.51%+$14.38M
Ascendis Pharma A/S(ASND)206,234152,175-54,059$55.01M$34.67M4.22%-$20.34M
Rhythm Pharmaceuticals, Inc.(RYTM)311,461348,317+36,856$34.58M$33.17M4.04%-$1.42M
Biogen Inc.(BIIB)48,101112,790+64,689$10.39M$25.48M3.10%+$15.08M
Immunovant, Inc.(IMVT)619,096624,055+4,959$23.85M$21.08M2.57%-$2.77M
Dianthus Therapeutics, Inc.(DNTH)390,000236,582-153,418$38.02M$20.83M2.54%-$17.19M
Oruka Therapeutics, Inc.(ORKA)352,802247,918-104,884$33.58M$20.65M2.52%-$12.93M
Erasca, Inc.(ERAS)1,263,0261,330,455+67,429$23.14M$19.50M2.38%-$3.63M
ABIVAX Société AnonymeADS(ABVX)169,593175,699+6,106$22.60M$17.40M2.12%-$5.20M
Celldex Therapeutics, Inc.(CLDX)0487,589+487,589$0$15.80M1.92%+$15.80M
Ovid Therapeutics Inc.(OVID)3,101,1295,950,000+2,848,871$8.34M$14.82M1.80%+$6.47M
Spyre Therapeutics, Inc.(SYRE)59,959151,151+91,192$5.32M$13.46M1.64%+$8.13M
Definium Therapeutics, Inc.(DFTX)400,000345,946-54,054$18.82M$13.17M1.60%-$5.65M
Helix Acquisition Corp. IIICL A(HLXC)1,177,8211,208,030+30,209$12.53M$12.83M1.56%+$297.3K
Alkermes plcSHS(ALKS)113,494300,427+186,933$5.95M$12.17M1.48%+$6.23M
C4 Therapeutics, Inc.(CCCC)3,032,0603,454,647+422,587$14.16M$11.50M1.40%-$2.66M
Avalyn Pharmaceuticals Inc330,487378,352+47,865$10.88M$10.78M1.31%-$100.4K
Cerus Corporation(CERS)3,472,7373,950,595+477,858$10.14M$9.40M1.15%-$738.0K
ALX Oncology Holdings Inc.(ALXO)5,744,7576,565,960+821,203$11.89M$9.13M1.11%-$2.76M
Zenas BioPharma, Inc.(ZBIO)509,789334,057-175,732$12.94M$9.01M1.10%-$3.93M
COMPASS Pathways plcADS(CMPS)503,382717,356+213,974$7.12M$8.92M1.09%+$1.80M
Rainier Acquisition CorpUNIT 08 24 20310853,875+853,875$0$8.71M1.06%+$8.71M
Compugen Ltd.(CGEN)3,184,2573,586,785+402,528$6.81M$8.54M1.04%+$1.72M
Savara Inc.(SVRA)1,355,4591,518,833+163,374$8.35M$7.84M0.95%-$512.4K
Vaxcyte, Inc.(PCVX)145,000125,080-19,920$8.43M$7.12M0.87%-$1.31M
Yarrow Bioscience Inc0301,919+301,919$0$6.80M0.83%+$6.80M
iBio, Inc.(IBIO)3,520,4905,357,088+1,836,598$6.16M$6.32M0.77%+$160.5K
Arcturus Therapeutics Holdings Inc.(ARCT)0459,899+459,899$0$6.30M0.77%+$6.30M
Praxis Precision Medicines, Inc.(PRAX)65,67919,753-45,926$21.99M$5.75M0.70%-$16.24M
Kiniksa Pharmaceuticals International, plcCL A(KNSA)075,697+75,697$0$5.65M0.69%+$5.65M
Enliven Therapeutics Inc489,382121,452-367,930$24.84M$5.57M0.68%-$19.27M
Solid Biosciences Inc668,450760,337+91,887$6.68M$5.50M0.67%-$1.18M
Evommune, Inc.(EVMN)0594,027+594,027$0$4.91M0.60%+$4.91M
Syndax Pharmaceuticals, Inc.(SNDX)1,214,390247,418-966,972$26.55M$4.65M0.57%-$21.90M
Benitec Biopharma Inc.(BNTC)679,826443,109-236,717$9.10M$4.43M0.54%-$4.66M
Research Alliance Corp IiiCL A360,000404,728+44,728$3.85M$4.38M0.53%+$531.2K
Blossomhill Therapeutics Inc0202,104+202,104$0$3.77M0.46%+$3.77M
Faeth Therapeutics, Inc.(FTH)0124,098+124,098$0$3.69M0.45%+$3.69M
Abeona Therapeutics Inc.(ABEO)610,407693,441+83,034$3.77M$3.64M0.44%-$131.8K
Research Alliance Corp IvCL A0301,962+301,962$0$3.50M0.43%+$3.50M
Adlai Nortye Group Ltd.ADS(ANL)0216,617+216,617$0$3.47M0.42%+$3.47M
Palisade Bio, Inc.(PALI)02,335,602+2,335,602$0$3.15M0.38%+$3.15M
Disc Medicine, Inc.(IRON)82,80047,312-35,488$6.06M$3.10M0.38%-$2.96M
TELA Bio, Inc.(TELA)2,137,2012,137,2010$1.60M$2.46M0.30%+$854.9K
Zevra Therapeutics, Inc.(ZVRA)0200,260+200,260$0$2.20M0.27%+$2.20M
ORIC Pharmaceuticals, Inc.(ORIC)738,873160,552-578,321$8.00M$2.16M0.26%-$5.84M
Contineum Therapeutics, Inc.CL A(CTNM)296,135158,964-137,171$4.85M$2.13M0.26%-$2.72M
Moderna, Inc.(MRNA)010,000+10,000$0$1.93M0.23%+$1.93M
Elutia Inc.CL A(ELUT)2,192,9802,192,9800$2.15M$1.73M0.21%-$415.8K
uniQure N.V.SHS(QURE)105,00056,704-48,296$4.84M$1.37M0.17%-$3.47M
Achieve Life Science Inc227,178158,950-68,228$1.48M$1.29M0.16%-$197.6K
Aclaris Therapeutics, Inc.(ACRS)1,946,482238,541-1,707,941$10.30M$1.25M0.15%-$9.04M
Rapport Therapeutics, Inc.(RAPP)035,524+35,524$0$1.19M0.15%+$1.19M
CAMP4 THERAPEUTICS CORPORATION(CAMP)653,594183,063-470,531$2.86M$739.6K0.09%-$2.12M
Zura Bio LimitedCL A(ZURA)0100,000+100,000$0$416.0K0.05%+$416.0K
Cellectar Biosciences, Inc.(CLRB)321,728151,118-170,610$894.4K$278.1K0.03%-$616.3K
Adagio Medical Holdings, Inc.(ADGM)224,360170,460-53,900$146.2K$26.1K0.00%-$120.1K
Artiva Biotherapeutics, Inc.(ARTV)525,0000-525,000$5.09M$0—-$5.09M
Avalo Therapeutics, Inc.(AVTX)500,4020-500,402$9.25M$0—-$9.25M
Connect Biopharma Holdings LimitedSHS(CNTB)545,0000-545,000$1.30M$0—-$1.30M
Crescent Biopharma, Inc.(CBIO)59,1040-59,104$1.06M$0—-$1.06M
Foghorn Therapeutics Inc.(FHTX)45,9750-45,975$224.4K$0—-$224.4K
Fractyl Health, Inc.(GUTS)1,637,9760-1,637,976$1.30M$0—-$1.30M
GeneDx Holdings Corp.CL A(WGS)122,2690-122,269$8.39M$0—-$8.39M
Guardant Health, Inc.(GH)99,8260-99,826$14.98M$0—-$14.98M
Insmed Incorporated(INSM)34,4380-34,438$3.67M$0—-$3.67M
Karyopharm Therapeutics Inc.(KPTI)297,4600-297,460$2.91M$0—-$2.91M
Revolution Medicines, Inc.(RVMD)10,0000-10,000$1.87M$0—-$1.87M
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)104,8280-104,828$356$0—-$356
Sionna Therapeutics, Inc.(SION)42,4780-42,478$1.87M$0—-$1.87M
Trevi Therapeutics, Inc.(TRVI)678,0950-678,095$12.65M$0—-$12.65M
Veracyte, Inc.(VCYT)318,0010-318,001$18.68M$0—-$18.68M
Veradermics, Incorporated(MANE)95,0000-95,000$11.68M$0—-$11.68M
Xenon Pharmaceuticals Inc.(XENE)186,8210-186,821$11.28M$0—-$11.28M
Page 1 of 1
SILVERARC CAPITAL MANAGEMENT, LLC — 13F Holdings — Q3 2026 | TickerTrail